Fri, August 16, 2024
Thu, August 15, 2024
Wed, August 14, 2024

Raghuram Selvaraju Reiterated (URGN) at Strong Buy and Held Target at $60 on, Aug 15th, 2024


//stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-60-on-aug-15th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "UroGen Pharma Ltd." (URGN) at Strong Buy and Held Target at $60 on, Aug 15th, 2024.

Raghuram has made no other calls on URGN in the last 4 months.



There are 2 other peers that have a rating on URGN. Out of the 2 peers that are also analyzing URGN, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $40 on, Friday, June 14th, 2024
  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $54 on, Friday, June 14th, 2024

Publication Contributing Sources